2025-08-19 - Analysis Report
Okay, here's an analysis of Hims & Hers Health Inc (HIMS) based on the provided data, presented in a structured format with an English report followed by simple analysis:

## Hims & Hers Health Inc (HIMS) Analysis

**Company Overview:** Hims & Hers Health Inc is a telehealth company that provides access to prescription medications and over-the-counter products online.

**1. Performance vs. S&P 500 (VOO)**

*   **HIMS Cumulative Return:** 169.97%
*   **VOO (S&P 500) Cumulative Return:** 69.44%
*   **Absolute Spread:** 103.7 (HIMS significantly outperforms VOO)
*   **Spread Range:** Max 286.3, Min -89.9
*   **Relative Spread:** 51.5 (The current spread is in the middle of its historical range)

**Analysis:** HIMS has significantly outperformed the S&P 500, but the current spread is around the middle of its historical fluctuation, meaning it can perform better or worse compared to the index.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta   | Cap(B) |
|------------|---------|---------|---------|--------|--------|
| 2019-2021  | -46.0%  | 51.0%  | -84.0% | -0.0   | 1.5   |
| 2020-2022  | -15.0%  | 72.1%  | -17.0%  | -0.0   | 1.4   |
| 2021-2023  | -51.0%  | 72.1%  | -69.0%  | -0.1   | 2.0   |
| 2022-2024  | 127.0% | 78.4%  | 101.0% | -0.1   | 5.5   |
| 2023-2025  | 165.0% | 79.6%  | 112.0% | -0.1   | 10.2   |

**Analysis:**

*   **CAGR:** The Compounded Annual Growth Rate shows a volatile past.
*   **MDD:** The Maximum Drawdown values are high, indicating significant price volatility and risk.
*   **Alpha:** Alpha values are mostly negative in the past, indicating underperformance relative to the benchmark, except recent data.
*   **Beta:** Beta values are close to zero, suggesting that HIMS' price movements are not strongly correlated with the overall market.
*   **Cap(B):** The company's market capitalization has increased significantly, indicating growth in the company's size and investor confidence.

**2. Recent Price Action**

*   **Current Price:** \$45.10
*   **Previous Close:** \$46.02
*   **Change:** -2.0% (Notable decline from previous close)
*   **5-Day Moving Average:** 46.91
*   **20-Day Moving Average:** 54.69
*   **60-Day Moving Average:** 53.08

**Analysis:** The stock is trading below all its moving averages, indicating a short-term and medium-term downward trend.  The 2% drop from the previous close suggests negative momentum.

**3. Market Risk Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.3285 (Low Risk)
*   **RSI:** 25.62 (Oversold)
*   **PPO:** -2.89 (Negative Momentum)
*   **Hybrid Signal:** Cash_70%_Sell 0.4% of holdings (5 shares - Caution - MRI:0.33) (Cash Ratio: 70% on 2025-08-08)
*   **Recent (20-Day) Relative Spread Change:** -2.1 (Short-term decline relative to S&P 500)
*   **Expected Return:** -18.0% (Long-term underperformance vs. S&P 500)

**Analysis:**

*   The RSI indicates the stock is currently oversold, which *could* signal a potential bounce-back.
*   The MRI indicates low market risk, which is a positive sign for long-term investment.
*   PPO is negative, signaling that the short-term moving average is below the long-term moving average.
*   The hybrid signal suggests a cautious approach, recommending selling a small portion of holdings.
*   However, the negative expected return suggests caution for long-term investment compared to the S&P 500.
*   The price change of -2.0% from previous close shows a significant negative change, and the short term price change has decreased significantly.

**4. Recent News & Significant Events**

*   **[2025-08-18]:** Business developments, regulatory changes, or market events impacting HIMS.
*   **[2025-08-19]:** Analyst discussions on HIMS' performance in the context of industry trends and economic factors.
*   **[2025-08-15]:** Notable stock volatility due to recent news, earnings, or executive actions.
*   **[2025-08-16]:** Mixed expert opinions, advising monitoring of news and announcements.

**Analysis:** Recent news points to potential catalysts (both positive and negative) impacting the stock. The volatility warning suggests increased risk.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue    |
|------------|------|------------|
| 2025-08-04 | 0.19 | \$0.54B     |
| 2025-05-05 | 0.22 | \$0.59B     |
| 2024-11-04 | 0.35 | \$0.40B     |
| 2024-08-05 | 0.06 | \$0.32B     |
| 2025-08-04 | 0.06 | \$0.32B     |

**Analysis:**

*   EPS and Revenue data show inconsistency and does not show a clear positive trend.
*   The drop in EPS from 0.35 to 0.06 between 2024-11-04 and 2024-08-05 (and then again on 2025-08-04) may need further investigation.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-06-30   | \$0.54B     | 76.39%        |
| 2025-03-31   | \$0.59B     | 73.50%        |
| 2024-12-31   | \$0.48B     | 76.81%        |
| 2024-09-30   | \$0.40B     | 79.16%        |
| 2024-06-30   | \$0.32B     | 81.30%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE      |
|--------------|------------|----------|
| 2025-06-30   | \$0.56B     | 7.55%    |
| 2025-03-31   | \$0.55B     | 9.01%    |
| 2024-12-31   | \$0.48B     | 5.46%    |
| 2024-09-30   | \$0.44B     | 17.18%   |
| 2024-06-30   | \$0.36B     | 3.67%    |

**Analysis:**

*   **Revenue:** Revenue has been generally increasing, indicating business growth.
*   **Profit Margin:** Profit margins are relatively high and stable, suggesting efficient operations.
*   **Equity:** Equity has grown over time, which is a good sign of financial health.
*   **ROE:** Return on Equity (ROE) is volatile, with a peak in 2024-09-30, which needs to be further investigated.

**7. Overall Summary**

Hims & Hers Health Inc (HIMS) demonstrates a mixed investment profile.  While it has significantly outperformed the S&P 500 historically, recent price action indicates a downward trend and heightened volatility.

*   **Positives:** High growth stock with good revenue and profit margins. Relatively high cumulative rate.
*   **Negatives:** Recent significant negative price action and the expected return is negative, indicating an underperformance of the S&P 500. Volatility and recent analyst discussion suggests risk.

**Recommendation:**

Given the mixed signals, a neutral to cautious approach is recommended. Investors should closely monitor upcoming news, earnings announcements, and analyst reports to reassess the investment outlook. The current hybrid signal is aligned with this recommendation.
